Aminophylline and isoprenaline, two drugs widely used in the managem2nt of asthma, have a pulmonary vasodilator action as well as a bronchodilator action. If regional pulmonary vasoconstriction in poorly ventilated parts of the lungs is a significant compensatory phenomenon in asthma, the effects of administration of these agents on gas exchange would depend on the relative magnitudes of bronchodilator action and pulmonary vasodilator action in the individual patient. If vasodilator action were greater than bronchodilator action in significant portions of the lungs, maldistribution of ventilation-blood flow ratios would increase and arterial oxygen tension might fall. In 40 patients with chronic asthma, arterial blood gas tensions, minute ventilation, alveolar-arterial oxygen tension gradient, physiological dead space/tidal volume ratio, and oxygen consumption were measured before and at intervals up to 20 to 40 minutes after the administration of various agents: in 13 patients, 250 mg. of aminophylline intravenously; in 16 patients, six deep inhalations of 1 % isoprenaline aerosol; in 11 patients, after various control procedures. There were no significant changes following the control procedures. Administration of both aminophylline and isoprenaline was followed by increases of F.E.V.1.0 and increases of minute ventilation. Despite these changes, five patients in each group showed a fall of arterial Po2 of 5 mm. Hg or more. This was accompanied by an increase of alveolar-arterial oxygen tension gradient. It was concluded that the decreases of arterial blood Po2 resulted from reversal of pre-existing, compensatory, regional pulmonary vasoconstriction by the pulmonary vasodilator action of each drug in some subjects.
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A fall of arterial oxygen tension or saturation has been demonstrated in some patients with irreversible chronic airflow obstruction following intravenous injection of aminophylline (Halmagyi and Cotes, 1959; Daly and Howard, 1965; Pain, Charlton, and Read, 1967 Isoprenaline shares with aminophylline the capacity to act both as a bronchodilator and as a pulmonary vasodilator. There is, however, a remarkable absence of data on the response of arterial blood gas tensions to the administration of aminophylline, isoprenaline, or other bronchodilator agents. The present paper reports detailed studies of blood gas tensions and other variables in 40 patients with bronchial asthma following intravenous aminophylline, inhaled isoprenaline, or an appropriate control procedure.
MATERIALS AND METHODS
The subjects of the present study ranged in age from 17 to 68 years (mean 43 years). All suffered from chronic asthma, which had been present for periods ranging from one year to most of their lives. The times shown by a pair of numbers include both of the minutes shown.
De Vilbiss No. 40 hand nebulizer. A further six samples of expired gas and arterial blood were collected over the succeeding 20 to 40 minutes at the times shown in Table II . Measurements of V.C. and F.E.V.1.o were repeated at the end of the experiment.
Eleven additional control experiments were performed. The procedure outlined above and in Table   II was followed, except that in five patients ('saline studies') 10 ml. of normal saline was injected instead of aminophylline; and in six others ('blank studies'), no isoprenaline was put in the nebulizer but six deep inhalations were made as before.
Oxygen tension in arterial blood samples (Po2) was measured with a polarographic electrode, and carbon dioxide tension (Pco2) with a Severinghaus electrode, both at 37 ± 0-1 C., with adequate calibration procedures. Minute ventilation (VE) was measured from the volumes of expired gas collected, and corrected to B.T.P.S. conditions. Oxygen and C02 concentrations in mixed expired gas were measured by Haldane analysis or with a respiratory mass spectrometer, and oxygen consumption (Vo2)) was calculated. VD/VT ratio (ratio of physiological dead space to tidal volume) was derived from arterial and mixed expired Pco2 values; it was not corrected for apparatus dead space (70 ml.), since we were concerned with changes of VD/VT ratio as a result of drug action. Alveolararterial oxygen tension gradients (A-a 02) were obtained from measured P02 and alveolar P02 derived from the alveolar air equation. Normal predicted F.E.V.1.o for each subject was taken to be 70% of the V.C. value predicted from the data of Needham, Rogan, and McDonald (1954) Figure 2 .
Among 13 patients given aminophylline, five showed an increase, five a decrease, and three no change in arterial Po2, using the limits defined above. The greatest mean increase was 6 mm. Hg, and the greatest mean decrease 10 mm. Hg. The largest individual increase of Po2 was 10 mm. Hg and the largest individual decrease 19 mm. Hg. Among the 16 patients who received isoprenaline, two showed an increase, five a decrease, and nine no change in arterial Po2; with greatest mean increases and decreases both of 8 mm. Hg. The largest individual increases and decreases of Po2 in this group were 8 and 11 mm. Hg. Those patients in both drug groups who showed a fall of arterial Po, had considerable increases of A-a 0.
(up to mean values of 11 mm. Hg), as did the subgroup showing no change of arterial Po2 after aminophylline. The remaining distinctions in Fig.  2 will be taken up in the Discussion.
In order to examine factors associated with the common increase in A-a 02, the data shown in Fig. 3 (Fig. 2) causes no surprise and calls for no further comment. Intuitively one might expect no other consequence than this following a lessening of airways obstruction (increase of F.E.V.1.0) and an increase in ventilation. That 10 patients (one-third of all subjects) should show a significant and sometimes large decrease of arterial P02 in the face of comparable increases of F.E.V.1.0 and of ventilation is surprising and requires closer examination. The decreases of Po2 were not transient; they were apparent by the time of the first post-drug measurement, and they persisted to a diminishing extent through the final measurements, made 20 to 40 minutes after drug administration.
We may readily exclude most of the theoretically possible causes of a decrease in Po2. There was no systematic increase of Vo2 of sufficient magnitude to account for this phenomenon in some patients but not in others. Aminophylline has usually, and isoprenaline invariably, been shown to cause an increase rather than a decrease of cardiac output, so that a fall in total pulmonary blood flow cannot account for the decreases in arterial Po,. Nor can they be ascribed to diminu-tion in total or in 'alveolar' ventilation, for changes in these were in the opposite direction. Inspired oxygen tension did not change during the studies. The only two remaining possibilities are increased maldistribution of ventilation-perfusion ratios and increased right-to-left shunting of blood. New anatomical right-to-left shunting channels have not been demonstrated (or even seriously postulated) in patients with asthma; and we are left with increased maldistribution of ventilationperfusion ratios as the only reasonable explanation. (In this context, continued blood flow through temporarily unventilated lung is treated as an extreme example of ventilation-perfusion ratio maldistribution rather than as a case of right-toleft shunt. Though the situation may be argued to be compatible with either classification, the functional mechanisms involved and the natural history have much more in common with ventilation-perfusion ratio maldistribution than with anatomical right-to-left shunt channels.)
The increased ventilation-perfusion ratio maldistribution may result from increased maldistribution of ventilation, of blood flow, or from further non-concordant maldistribution of both. Increased maldistribution of ventilation seems unlikely to be the essential cause. In each of the groups showing a decrease of arterial Po2, F.E.V.1.0 increased significantly following the drug, so that overall airways resistance was reduced. If the greatest proportional improvement in airways resistance occurred in regions of the lung with the greatest initial obstruction, an improvement in the distribution of inspired air and a rise of Po2 would be expected. Greater proportional improvement in airways resistance in initially less obstructed regions could theoretically lead to a worsening of inspired air distribution. But, in the presence of the increased ventilation almost invariably seen after the drugs, it is hard to conceive of the initially less well ventilated alveolar populations receiving even less ventilation than before the drug was given. It is very unlikely that the increased ventilation following drug administration led per se to any worsening of ventilation distribution. It will be recalled that the pattern was one of increased tidal volume with little increase in respiratory rate-a pattern which would be expected to lead to an improvement rather than a deterioration in the distribution of ventilation (Read, 1958) .
By a process of exclusion, a worsening of the distribution of pulmonary blood flow (in relation to ventilation) remains as the most likely cause of the decrease of arterial Po2. This mechanism is a perfectly reasonable one in its own right, for both aminophylline and isoprenaline are established pulmonary vasodilators as well as bronchodilators. We suggest that, in 10 patients, their pulmonary vasodilator action was more effective than their bronchodilator action. We think that, at least in some subjects, compensatory pulmonary vasoconstriction occurs in regions of the lungs which are poorly ventilated as a result of local airways obstruction. If the administration of aminophylline or isoprenaline causes a greater local increase in blood flow (vasodilator action) than in ventilation (bronchodilator action) in such poorly ventilated regions, the local ventilation-perfusion ratio will fall even further, and there will result a fall of arterial Po2. This phenomenon of reversal of regional, compensatory vasoconstriction must have been of considerable magnitude in the 10 subjects in the two groups III of Fig. 2 , since it was sufficient to cause a decrease of arterial Po2 in the face of overall improvement in airways obstruction and of considerable increases of total ventilation.
The increased A-a 02 seen in conjunction with the falls of arterial Po2 (Figs 2 and 3) is consistent with the interpretation that the decreases of Po2 result from increased ventilation-perfusion ratio maldistribution. The increased A-a°2 is not, of course, diagnostic of a primarily ventilatory or primarily perfusion basis for the increased maldistribution.
Changes in the VD/VT ratio, which is frequently a valuable index of ventilation-perfusion ratio maldistribution, were disappointingly small or negligible in most instances in the present study. One is obliged to conclude that, in the particular circumstances, A-a°2 was a more sensitive index of change in ventilation-perfusion ratio distribution.
The differences in response of arterial Po2 and A-a 02 between different subjects may be of considerable significance. It has been shown in this laboratory that normal subjects differ reproducibly in the extent of their pulmonary vascular response to hypoxia (Fowler and Read, 1963) and to exercise (Read and Fowler, 1964) ; and it has been suggested that normal subjects can be broadly divided into 'responders' and 'non-responders' as far as pulmonary vascular reactivity is concerned. If this apparently intrinsic and reproducible difference between individual normal subjects were carried over into disease states, one might expect that some patients would show evidence of compensatory regional pulmonary vasoconstriction and that some would not. The present range of responses would be consistent with such a hypo-thesis, 'responders' being those patients in whom A-a 02 increased after administration of the drugs.
In addition, the existence of regional compensatory vasoconstriction in the poorly ventilated regions of the lungs would move arterial blood gas tensions towards normal. One would expect 'responders' in general to have a higher arterial P°2 for a given degree of airways obstruction than non-responders. The data of Fig. 2 are again consistent with this section of the hypothesis. The patients showing a fall of Po2 and an increase of A-a 02 after receiving the drugs clearly had a higher mean initial Po2 than the other patients. Consideration of both mean and individual data showed that this was not simply due to their having higher initial F.E.V.1.0 levels. In the patients who received isoprenaline, the difference between initial Po. in sub-group III subjects and those in sub-groups I and II was statistically highly significant (difference between means four times the standard error of the difference). In the patients who received aminophylline, the difference in initial mean Po2 between apparent 'responders' and apparent 'non-responders' was large and in the appropriate direction but did not achieve standard statistical levels of significance.
The therapeutic significance of the changes in arterial P02 reported is difficult to assess. In no case was the fall in Po, a dangerous one, but a decrease of arterial Po2 occurred in as many as one-third of the patients following the administration of these two widely used 'standard' bronchodilators. We re-emphasize that the patients in this study had chronic asthma rather than acute episodes and that we must be cautious in extrapolating the results to the more acute clinical situation. However, the present demonstration that a decrease of arterial Po2 following administration of these agents is not uncommon suggests that it is unwise to assume that they are free from danger when used in acute episodes. At low levels of arterial Po2 in severe acute asthma, any further decrease of Po2 may threaten life. 
